Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer
Available from: . (). . . http://dx.doi.org/10.1101/056770
Read ItAvailable from: . (). . . http://dx.doi.org/10.1101/056770
Read ItThis user has not reviewed any papers.